In chronic inflammatory conditions such as cancer, prolonged T cell activation leads to increased CTLA-4-expressing Tregs and upregulation of CTLA-4 on cytotoxic T lymphocytes (CTLs), which interacts with the B7 family of receptors and leads to reduced T cell proliferation and survival (Figure 1) (38). The gene discussed is CTLA4; the disease is cancer.